US 2012/0276077 A1Published application

Therapeutic ribonucleases

AssigneeQuintessence Biosciences, Inc.

InventorsTony Klink, John Kink, Laura Strong

Life of this patent

Estimating the term…

Abstract

The present invention relates to the use of ribonucleases (RNases) in the treatment or prevention of disease.

Claims8

Dependent claims

A composition comprising a ribonuclease having a human RNase 1 sequence with amino acid modification:

R4C, G38R, R39G, N67R, G89R, S90R, and V118C.

Dependencies are inferred from the claim text.

Facts

Application: 13/545,387Filed 10 Jul 2012
Priority: 1 Oct 2008
Published: 1 Nov 2012
Term ends: Not estimatedThe source records don’t support an estimate.

Classification12 codes

A61K 38/465
Hydrolases: acting on ester bonds , e.g. lipases, ribonucleases
A61P 35/00
Antineoplastic agents
A61P 35/02
Antineoplastic agents: specific for leukemia
A61P 35/04
Antineoplastic agents: specific for metastasis

Family

Application61/101,905Us provisional application · filed 1 Oct 2008
Application12/572,016Continuation · filed 1 Oct 2009
Application13/231,050Continuation · filed 13 Sep 2011
Application13/545,387Continuation
US 2010/0080789 A1Published application
US 2012/0003150 A1Published application
US 8,029,782 B2Related patent
US 8,216,567 B2Related patent
US 8,628,768 B2Related patent
US 2012/0276077 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results